# BFNH (Bioforce Nanosciences Holdings, Inc.) - SEC EDGAR Financial Statements

> Bioforce Nanosciences Holdings, Inc. reported $786 in total assets and a net loss of $323K through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/BFNH
- Markdown: https://convexityos.com/fundamentals/BFNH.md
- SEC CIK: 0001310488
- Reporting currency: USD
- Latest filing period: December 31, 2026
- Last synced: Nov 20, 2026, 05:43 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001310488&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -- | Operating profit |
| Net Income | FY 2025 | -$323K | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.01 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Dec 31, 2026 | $786 | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | -- | -- | -- | $18K | $16K | $4.5K |
| Cost of Revenue | -- | -- | -- | -- | -- | -- | $13K | $12K | $3.2K |
| **Gross Profit** | -- | -- | -- | -- | -- | -- | $4.4K | $4.7K | $1.3K |
| Total Operating Expenses | $490K | $490K | $472K | $486K | $502K | $158.4M | $51K | -- | -- |
| **Operating Income** | -- | -- | -- | -- | -- | -- | -$47K | -$67K | -$31K |
| Income Before Tax | -$490K | -$490K | -- | -- | -- | -- | -$47K | -$68K | -$31K |
| Income Tax Expense | -- | -- | -- | -- | -- | -- | $0 | $0 | -- |
| **Net Income** | -$1.29M | -$490K | -$472K | -$486K | -$502K | -$158.4M | -$47K | -$68K | -$31K |
| Basic EPS | -$0.04 | -$0.02 | -$0.02 | -$0.02 | -$0.02 | -$9.72 | $0.00 | $0.00 | $0.00 |
| **Diluted EPS** | -$0.04 | -$0.02 | -$0.02 | -$0.02 | -$0.02 | -$9.72 | $0.00 | $0.00 | $0.00 |
| Basic Shares Outstanding | 33.2M | 29.3M | 29.3M | 29.3M | 29.3M | 16.3M | 15.3M | 15.3M | 76.2M |
| Diluted Shares Outstanding | 33.2M | 29.3M | 29.3M | 29.3M | 29.3M | 16.3M | 15.3M | 15.3M | 76.2M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Total Operating Expenses | $342K | $262K | $118K | $118K | $116K | $123K | $133K | $123K |
| **Operating Income** | -$342K | -$763K | -$133K | -- | -$116K | -$123K | -$133K | -- |
| Income Before Tax | -$342K | -$262K | -$118K | -$118K | -$116K | -$123K | -$133K | -- |
| **Net Income** | -$342K | $239K | -$102K | -$118K | -$116K | -$123K | -$935K | -$123K |
| Basic EPS | -$0.01 | $0.01 | $0.00 | -- | $0.00 | $0.00 | -$0.03 | -- |
| **Diluted EPS** | -$0.01 | $0.01 | $0.00 | -- | $0.00 | $0.00 | -$0.03 | -- |
| Basic Shares Outstanding | 35.0M | 33.5M | 33.5M | -- | 33.5M | 33.5M | 32.2M | -- |
| Diluted Shares Outstanding | 35.0M | 33.5M | 33.5M | -- | 33.5M | 33.5M | 32.2M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $786 | $862 | $638 | $734 | $11K | $40K | $53K | $29K | $14K |
| **Cash & Short-Term Investments** | $786 | $862 | $638 | $734 | $11K | $40K | $53K | $29K | $14K |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | -- | $5.7K | $4.5K |
| **Total Current Assets** | $786 | $862 | $638 | $734 | $11K | $40K | $59K | $35K | $21K |
| **Total Non-Current Assets** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Assets** | $786 | $862 | $638 | $734 | $11K | $40K | $59K | $35K | $21K |
| **Total Current Liabilities** | $619K | $2.30M | $1.82M | $1.35M | $873K | $400K | $12K | $5.3K | $13K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $619K | $2.30M | $1.82M | $1.35M | $873K | $400K | $12K | $5.3K | $13K |
| Common Stock | $34K | $29K | $29K | $29K | $29K | $29K | $15K | $15K | $76K |
| Retained Earnings | -$162.4M | -$161.1M | -$160.6M | -$160.2M | -$159.7M | -$159.2M | -$762K | -$715K | -$647K |
| **Total Stockholders' Equity** | -$619K | -$2.30M | -$1.82M | -$1.35M | -$862K | -$360K | $47K | $30K | $8.2K |
| Total Equity | -$619K | -$2.30M | -$1.82M | -$1.35M | -$862K | -$360K | $47K | $30K | $8.2K |

### Balance Sheet (Quarterly)

| Line Item | Dec 2026 | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $786 | $32K | $307 | $6.3K | $786 | $784 | $905 | $14K |
| **Cash & Short-Term Investments** | $786 | $32K | $307 | $6.3K | $786 | $784 | $905 | $14K |
| **Total Current Assets** | $786 | $2.00M | $2.15M | $6.3K | $786 | $784 | $905 | $14K |
| **Total Non-Current Assets** | $0 | $235K | $235K | $0 | $0 | $0 | $0 | $0 |
| **Total Assets** | $786 | $2.24M | $2.39M | $6.3K | $786 | $784 | $905 | $14K |
| **Total Current Liabilities** | $619K | $277K | $85K | $727K | $619K | $501K | $385K | $275K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $619K | $277K | $85K | $727K | $619K | $501K | $385K | $275K |
| Common Stock | $34K | $38K | $34K | $34K | $34K | $34K | $34K | $34K |
| Retained Earnings | -$162.4M | -$162.6M | -$162.3M | -$162.5M | -$162.4M | -$162.3M | -$162.2M | -$162.1M |
| **Total Stockholders' Equity** | -$619K | $1.96M | $2.30M | -$721K | -$619K | -$500K | -$384K | -$261K |
| Total Equity | -$619K | $1.96M | $2.30M | -$721K | -$619K | -$500K | -$384K | -$261K |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.29M | -$490K | -$472K | -$486K | -$502K | -$158.4M | -$47K | -$68K | -$31K |
| Change in Receivables | -- | -- | -- | -- | -- | -- | $5.7K | -$1.2K | -$4.5K |
| **Operating Cash Flow** | -$65K | -$61K | -$47K | -$68K | -$78K | -$80K | -$24K | -$62K | -$26K |
| **Financing Cash Flow** | $65K | $61K | $47K | $58K | $49K | $67K | $48K | -- | -- |
| **Net Change in Cash** | -$76 | $224 | -$96 | -$10K | -$29K | -$13K | -- | -- | -- |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$342K | $239K | -$102K | -$118K | -$116K | -$123K | -$935K | -$123K |
| **Operating Cash Flow** | -$95K | -$27K | $7.1K | -$11K | -$11K | -$28K | -$15K | -$15K |
| **Financing Cash Flow** | $126K | $21K | -$1.5K | $11K | $11K | $15K | $28K | $14K |
| **Net Change in Cash** | $31K | -$6.0K | $5.6K | $2 | -$121 | -$13K | $13K | -$773 |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | -- | -- | -- | 24.5% | 28.6% | 27.9% |
| **Operating Margin** | -- | -- | -- | -- | -- | -- | -261.8% | -409.2% | -694.7% |
| **Net Profit Margin** | -- | -- | -- | -- | -- | -- | -261.8% | -415.3% | -694.7% |
| Return on Equity (ROE) | -- | -- | -- | -- | -- | -- | -98.4% | -227.3% | -381.1% |
| Return on Assets (ROA) | -164370.4% | -56895.2% | -73973.8% | -66146.3% | -4503.9% | -397362.5% | -79.0% | -192.8% | -149.5% |
| Current Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.10x | 5.08x | 6.60x | 1.65x |
| Quick Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.10x | 4.57x | 6.60x | 1.48x |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -- | -- | +9.0% | +262.4% | -- |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -- | -6.5% | +271.7% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -16.5% | -4.2% | -- | -- | -- | -- | -- | -- |
| Return on Assets (ROA) | -14.4% | -4.1% | -7230.3% | -164370.4% | -165473.6% | -144024.5% | -9385.3% | -56895.2% |
| Current Ratio | 7.23x | 25.41x | 0.01x | 0.00x | 0.00x | 0.00x | 0.05x | 0.00x |
| Quick Ratio | 0.11x | 0.00x | 0.01x | 0.00x | 0.00x | 0.00x | 0.05x | 0.00x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
